Success Story: Our Firm Helped a Validation Specialist Secure NIW Approval With No RFE
Client’s Testimonial:
“Thank you; I’m grateful you’re willing to take my case and for your patience. You have excellent communication: speaking on a point-by-point basis and responding to the deluge of my inquiries (sorry about that). I like how you write the letters, very clever and creative! I even find them very entertaining to read! You nailed them well and worded complex ideas in a very accessible and convincing way. Also, thanks for explaining the visa rulings, too. Overall, I am grateful for your service and the EB-2 NIW experience! Worth every single dollar and cent!”
On October 28th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Validation Specialist in the Field of Materials Science and Engineering (Approval Notice).
General Field: Materials Science and Engineering
Position at the Time of Case Filing: Validation Specialist
Country of Origin: Indonesia
State of Residence at the Time of Filing: Kentucky
Approval Notice Date: October 28th, 2025
Processing Time: 21 months, 4 days
Case Summary:
“Undoubtedly, [Client’s] contributions wield a profound impact within the esteemed scientific community in the United States – an impact underscored by the publication of his groundbreaking work in prestigious venues such as Nature and Science Advances.”
This compelling recognition came from one of the four expert recommendation letters included in our client’s National Interest Waiver (NIW) petition. The client, an advanced materials scientist with an M.S. in pharmaceutical sciences, chose North America Immigration Law Group (Chen Immigration) to represent the case before USCIS. We are thrilled to share that the petition was successfully approved under the EB-2 NIW category without a Request for Evidence (RFE).
Our legal strategy focused on proving both the national significance of the client’s proposed endeavor and his ability to continue advancing impactful research. The client’s work centers on streamlining pre-formulation and formulation processes to enhance oral drug delivery and pharmaceutical manufacturing efficiency, leading to improved patient outcomes and more sustainable production practices within the U.S. healthcare system.
To clearly support NIW approval, our team highlighted the following noteworthy accomplishments:
-
The client has already made respected contributions as an expert in materials science and engineering, applying advanced techniques for pharmaceutical materials characterization and drug formulation.
-
The research record includes 3 peer-reviewed journal articles, one abstract, one preprint, and one patent, reflecting productivity and technical leadership in the field.
-
The client’s published work has earned 433 citations, demonstrating widespread reliance on the client’s findings by other scientists seeking to improve material performance and biomedical applications.
-
The petition included evidence of major funding sources supporting the client’s research contributions, including initiatives supported by:
– The National Science Foundation (NSF)
– The Army Research Office (ARO)
– The Department of Energy’s Basic Energy Sciences (BES)
– The Walter Burke Institute for Theoretical Physics
– The Gordon and Betty Moore Foundation’s EPiQS Initiative
In our comprehensive petition letter, we reinforced how the client is exceptionally well-positioned to continue advancing a nationally important endeavor, especially in areas identified by the U.S. government as critical life-sciences technology sectors.
We are pleased to celebrate this NIW approval and proud to play a role in supporting the client’s promising scientific career in the United States.